COPD and glycopyrronium responsiveness assessment: An appraisal

BACKGROUND: Glycopyrronium bromide (a long-acting antimuscarinic agent: LAMA) appears pharmacokinetically suitable for testing bronchodilator responsiveness as salbutamol (short-acting β2-agonist: SABA). Exploring the feasibility, acceptability, degree of reversibility with glycopyrronium, and its c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhattacharyya, Parthasarathi, Saha, Dipanjan, Chatterjee, Moumita, Sengupta, Sayoni, Dey, Debkanya, Banerjee, Rajat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298818/
https://www.ncbi.nlm.nih.gov/pubmed/37148020
http://dx.doi.org/10.4103/lungindia.lungindia_376_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298818/
https://www.ncbi.nlm.nih.gov/pubmed/37148020
http://dx.doi.org/10.4103/lungindia.lungindia_376_22

Ejemplares similares